GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-05

AUTHORS

Eliza A. Hawkes, Sarah Barton, David Cunningham, Clare Peckitt, Sue Chua, Andrew Wotherspoon, Alan Horwich, Mike Potter, Mark Ethel, Claire Dearden, Ian Chau

ABSTRACT

Hodgkin lymphoma (HL) is a relatively chemosensitive malignancy. However, for those who relapse, high-dose chemotherapy with autologous stem cell transplant is the treatment of choice which relies on adequate disease control with salvage chemotherapy. Regimens commonly used often require inpatient administration and can be difficult to deliver due to toxicity. Gemcitabine and cisplatin have activity in HL, non-overlapping toxicity with first-line chemotherapeutics, and may be delivered in an outpatient setting. In this retrospective single-centre analysis, patients with relapsed or refractory HL treated with gemcitabine 1,000 mg/m(2) day (D)1, D8 and D15; methylprednisolone 1,000 mg D1-5; and cisplatin 100 mg/m(2) D15, every 28 days (GEM-P) were included. Demographic, survival, response and toxicity data were recorded. Forty-one eligible patients were identified: median age 27. One hundred and twenty-two cycles of GEM-P were administered in total (median 3 cycles; range 1-6). Twenty of 41 (48 %) patients received GEM-P as second-line treatment and 11/41 (27 %) as third-line therapy. Overall response rate (ORR) to GEM-P in the entire cohort was 80 % (complete response (CR) 37 %, partial response 44 %) with 14/15 CR confirmed as a metabolic CR on PET and ORR of 85 % in the 20 second-line patients. The most common grade 3/4 toxicities were haematological: neutropenia 54 % and thrombocytopenia 51 %. Median follow-up from the start of GEM-P was 4.5 years. Following GEM-P, 5-year progression-free survival was 46 % (95 % confidence interval (CI), 30-62 %) and 5-year overall survival was 59 % (95 % CI, 43-74 %). Fourteen of 41 patients proceeded directly to autologous transplant. GEM-P is a salvage chemotherapy with relatively high response rates, leading to successful transplantation in appropriate patients, in the treatment of relapsed or refractory HL. More... »

PAGES

827-834

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-013-1930-y

DOI

http://dx.doi.org/10.1007/s00277-013-1930-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010145040

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24158386


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hodgkin Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylprednisolone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neutropenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hawkes", 
        "givenName": "Eliza A.", 
        "id": "sg:person.01000200404.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000200404.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barton", 
        "givenName": "Sarah", 
        "id": "sg:person.0732065204.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732065204.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "David", 
        "id": "sg:person.01320161130.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peckitt", 
        "givenName": "Clare", 
        "id": "sg:person.01332410360.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332410360.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chua", 
        "givenName": "Sue", 
        "id": "sg:person.0737666052.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737666052.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wotherspoon", 
        "givenName": "Andrew", 
        "id": "sg:person.01000107664.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000107664.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horwich", 
        "givenName": "Alan", 
        "id": "sg:person.01140223356.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140223356.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Potter", 
        "givenName": "Mike", 
        "id": "sg:person.016310433302.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016310433302.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ethel", 
        "givenName": "Mark", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dearden", 
        "givenName": "Claire", 
        "id": "sg:person.01064766557.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064766557.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chau", 
        "givenName": "Ian", 
        "id": "sg:person.01035560774.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035560774.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/cncr.21587", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000306080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21587", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000306080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002994219", 
          "https://doi.org/10.1038/sj.bjc.6602514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002994219", 
          "https://doi.org/10.1038/sj.bjc.6602514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/07357900701788098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005564175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2011.045757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006538660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1100340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009739876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2003.04226.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010001288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-10-388058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013984890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10428190903040048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015304457"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm090", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016019825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)08938-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019434820"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2012.04.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021850522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.0410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023394934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2011.08594.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026107393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-009-0734-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027539919", 
          "https://doi.org/10.1007/s00277-009-0734-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-009-0734-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027539919", 
          "https://doi.org/10.1007/s00277-009-0734-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-009-0734-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027539919", 
          "https://doi.org/10.1007/s00277-009-0734-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1026454831340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034772808", 
          "https://doi.org/10.1023/a:1026454831340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdf221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036637430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000077995", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042104091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042263281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-03-418673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042810056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-010-1113-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045085566", 
          "https://doi.org/10.1007/s00277-010-1113-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2011.04.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045304632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2011.047670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046325083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2011-0177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046459955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/clm.2004.n.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046538125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdg496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046913073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.1350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047229119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)92411-l", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047684969"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10428194.2012.734612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048817281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa022473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049524002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-12-397893", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052251769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10245330701214095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058358185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.2.467", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202763"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.4.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082379300", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05", 
    "datePublishedReg": "2014-05-01", 
    "description": "Hodgkin lymphoma (HL) is a relatively chemosensitive malignancy. However, for those who relapse, high-dose chemotherapy with autologous stem cell transplant is the treatment of choice which relies on adequate disease control with salvage chemotherapy. Regimens commonly used often require inpatient administration and can be difficult to deliver due to toxicity. Gemcitabine and cisplatin have activity in HL, non-overlapping toxicity with first-line chemotherapeutics, and may be delivered in an outpatient setting. In this retrospective single-centre analysis, patients with relapsed or refractory HL treated with gemcitabine 1,000\u00a0mg/m(2) day (D)1, D8 and D15; methylprednisolone 1,000\u00a0mg D1-5; and cisplatin 100\u00a0mg/m(2) D15, every 28\u00a0days (GEM-P) were included. Demographic, survival, response and toxicity data were recorded. Forty-one eligible patients were identified: median age 27. One hundred and twenty-two cycles of GEM-P were administered in total (median 3 cycles; range 1-6). Twenty of 41 (48\u00a0%) patients received GEM-P as second-line treatment and 11/41 (27\u00a0%) as third-line therapy. Overall response rate (ORR) to GEM-P in the entire cohort was 80\u00a0% (complete response (CR) 37\u00a0%, partial response 44\u00a0%) with 14/15 CR confirmed as a metabolic CR on PET and ORR of 85\u00a0% in the 20 second-line patients. The most common grade 3/4 toxicities were haematological: neutropenia 54\u00a0% and thrombocytopenia 51\u00a0%. Median follow-up from the start of GEM-P was 4.5\u00a0years. Following GEM-P, 5-year progression-free survival was 46\u00a0% (95\u00a0% confidence interval (CI), 30-62\u00a0%) and 5-year overall survival was 59\u00a0% (95\u00a0% CI, 43-74\u00a0%). Fourteen of 41 patients proceeded directly to autologous transplant. GEM-P is a salvage chemotherapy with relatively high response rates, leading to successful transplantation in appropriate patients, in the treatment of relapsed or refractory HL. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-013-1930-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma", 
    "pagination": "827-834", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3054faa23264546fc78182f135b50a57b27c1f52777133b244e9429664a988ce"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24158386"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-013-1930-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010145040"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-013-1930-y", 
      "https://app.dimensions.ai/details/publication/pub.1010145040"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000582.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-013-1930-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1930-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1930-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1930-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1930-y'


 

This table displays all metadata directly associated to this object as RDF triples.

327 TRIPLES      21 PREDICATES      84 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-013-1930-y schema:about N196da086558146da99ec7aace4b7e0a1
2 N19f58671232d4b4c8a56a36cc37798c5
3 N2433c3091ed8444899b9f6ec8f7047a8
4 N26643ca38a5e480a87cbccfa6281e83f
5 N2ca1b47beb634c67bb172c669bfc0d0b
6 N33091afc932e4490bbad02f2fa8bfeb9
7 N3e91c8b1bdf0459cb45689f8eb1bc719
8 N63b670b5792f4042bb2323fa2deb267a
9 N671aa454c56c46a3bddcd7a56d03435e
10 N697ccb2281544173aa8552b727d67714
11 N839b32609d044142b2735571aec6d84e
12 N84d8e12281424bcca8cf176153384b42
13 Nb9d5f413d1cb4aca8d52916affb98e24
14 Nc0a234a21818420c97929255b9af1baa
15 Nc58b639eba3f40e6af006ca7f64675b0
16 Nc67455d176b3495b8e01d23949e551da
17 Ncbb0edf8e015462a875319eb24a463e2
18 Nd2a2407556574b8aad07f91a5efc8e24
19 Ne0de740ea7f04740988323814d161b80
20 Nf6db20da4ac54203b847ab38fc0ad7a2
21 Nf81328d0c5d1410d8fdad160f9b91d08
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author Ne2fa6a6738494e92aed97aea1091c1b4
25 schema:citation sg:pub.10.1007/s00277-009-0734-6
26 sg:pub.10.1007/s00277-010-1113-z
27 sg:pub.10.1023/a:1026454831340
28 sg:pub.10.1038/sj.bjc.6602514
29 https://app.dimensions.ai/details/publication/pub.1082379300
30 https://doi.org/10.1002/cncr.21587
31 https://doi.org/10.1016/0140-6736(93)92411-l
32 https://doi.org/10.1016/j.bbmt.2011.04.011
33 https://doi.org/10.1016/j.ijrobp.2012.04.007
34 https://doi.org/10.1016/s0140-6736(02)08938-9
35 https://doi.org/10.1046/j.1365-2141.2003.04226.x
36 https://doi.org/10.1056/nejmoa022473
37 https://doi.org/10.1056/nejmoa1100340
38 https://doi.org/10.1080/07357900701788098
39 https://doi.org/10.1080/10245330701214095
40 https://doi.org/10.1080/10428190903040048
41 https://doi.org/10.1093/annonc/mdf221
42 https://doi.org/10.1093/annonc/mdg496
43 https://doi.org/10.1093/annonc/mdi003
44 https://doi.org/10.1093/annonc/mdm090
45 https://doi.org/10.1111/j.1365-2141.2011.08594.x
46 https://doi.org/10.1159/000077995
47 https://doi.org/10.1182/blood-2011-10-388058
48 https://doi.org/10.1182/blood-2011-12-397893
49 https://doi.org/10.1182/blood-2012-03-418673
50 https://doi.org/10.1200/jco.1999.17.4.1244
51 https://doi.org/10.1200/jco.20.2.467
52 https://doi.org/10.1200/jco.2011.38.0410
53 https://doi.org/10.1200/jco.2011.38.1350
54 https://doi.org/10.1634/theoncologist.2011-0177
55 https://doi.org/10.3109/10428194.2012.734612
56 https://doi.org/10.3324/haematol.2011.045757
57 https://doi.org/10.3324/haematol.2011.047670
58 https://doi.org/10.3816/clm.2004.n.009
59 schema:datePublished 2014-05
60 schema:datePublishedReg 2014-05-01
61 schema:description Hodgkin lymphoma (HL) is a relatively chemosensitive malignancy. However, for those who relapse, high-dose chemotherapy with autologous stem cell transplant is the treatment of choice which relies on adequate disease control with salvage chemotherapy. Regimens commonly used often require inpatient administration and can be difficult to deliver due to toxicity. Gemcitabine and cisplatin have activity in HL, non-overlapping toxicity with first-line chemotherapeutics, and may be delivered in an outpatient setting. In this retrospective single-centre analysis, patients with relapsed or refractory HL treated with gemcitabine 1,000 mg/m(2) day (D)1, D8 and D15; methylprednisolone 1,000 mg D1-5; and cisplatin 100 mg/m(2) D15, every 28 days (GEM-P) were included. Demographic, survival, response and toxicity data were recorded. Forty-one eligible patients were identified: median age 27. One hundred and twenty-two cycles of GEM-P were administered in total (median 3 cycles; range 1-6). Twenty of 41 (48 %) patients received GEM-P as second-line treatment and 11/41 (27 %) as third-line therapy. Overall response rate (ORR) to GEM-P in the entire cohort was 80 % (complete response (CR) 37 %, partial response 44 %) with 14/15 CR confirmed as a metabolic CR on PET and ORR of 85 % in the 20 second-line patients. The most common grade 3/4 toxicities were haematological: neutropenia 54 % and thrombocytopenia 51 %. Median follow-up from the start of GEM-P was 4.5 years. Following GEM-P, 5-year progression-free survival was 46 % (95 % confidence interval (CI), 30-62 %) and 5-year overall survival was 59 % (95 % CI, 43-74 %). Fourteen of 41 patients proceeded directly to autologous transplant. GEM-P is a salvage chemotherapy with relatively high response rates, leading to successful transplantation in appropriate patients, in the treatment of relapsed or refractory HL.
62 schema:genre research_article
63 schema:inLanguage en
64 schema:isAccessibleForFree false
65 schema:isPartOf N01d135ca121b435b969b2b375f5f3d05
66 Nbee217737fdf418883d1c9f3ef722e09
67 sg:journal.1018247
68 schema:name GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma
69 schema:pagination 827-834
70 schema:productId N0fdfcdcd420c424a917f7156b2460f2e
71 N3d0b429603524b1e977fb65991e02350
72 Na77c3369689c43d1a667cb66883a56fc
73 Naf2480e64f3b452281837d94520e6c7e
74 Nbae282c1decc48359613a70c68134d5d
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010145040
76 https://doi.org/10.1007/s00277-013-1930-y
77 schema:sdDatePublished 2019-04-10T18:30
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N15904ca14ca04581836318af52e2616b
80 schema:url http://link.springer.com/10.1007/s00277-013-1930-y
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N00eb8262699e4f28a6870ec54e597e15 rdf:first sg:person.01332410360.78
85 rdf:rest N445c8f80fc314a3097a0de3e7e4723d9
86 N01d135ca121b435b969b2b375f5f3d05 schema:volumeNumber 93
87 rdf:type schema:PublicationVolume
88 N0fdfcdcd420c424a917f7156b2460f2e schema:name dimensions_id
89 schema:value pub.1010145040
90 rdf:type schema:PropertyValue
91 N10718d30b1ec48819638dec899d937d3 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
92 schema:familyName Ethel
93 schema:givenName Mark
94 rdf:type schema:Person
95 N15904ca14ca04581836318af52e2616b schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 N196da086558146da99ec7aace4b7e0a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Methylprednisolone
99 rdf:type schema:DefinedTerm
100 N19f58671232d4b4c8a56a36cc37798c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Survival Analysis
102 rdf:type schema:DefinedTerm
103 N2433c3091ed8444899b9f6ec8f7047a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Transplantation, Autologous
105 rdf:type schema:DefinedTerm
106 N26643ca38a5e480a87cbccfa6281e83f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Drug Administration Schedule
108 rdf:type schema:DefinedTerm
109 N2ca1b47beb634c67bb172c669bfc0d0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Aged
111 rdf:type schema:DefinedTerm
112 N33091afc932e4490bbad02f2fa8bfeb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Recurrence
114 rdf:type schema:DefinedTerm
115 N3d0b429603524b1e977fb65991e02350 schema:name doi
116 schema:value 10.1007/s00277-013-1930-y
117 rdf:type schema:PropertyValue
118 N3e91c8b1bdf0459cb45689f8eb1bc719 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Treatment Outcome
120 rdf:type schema:DefinedTerm
121 N445c8f80fc314a3097a0de3e7e4723d9 rdf:first sg:person.0737666052.34
122 rdf:rest N8d7252bad0834dbaacb7a30a1a98849a
123 N4c46040ca80b4f88be15ad0fc40fedf9 rdf:first N10718d30b1ec48819638dec899d937d3
124 rdf:rest N9014c3ffe47444f0a5946acb0e803bb9
125 N561314a17edf4be5aa37c845a4082c89 rdf:first sg:person.01035560774.45
126 rdf:rest rdf:nil
127 N57f6bae7129e49d9aa5d7c1df6459ee5 rdf:first sg:person.016310433302.65
128 rdf:rest N4c46040ca80b4f88be15ad0fc40fedf9
129 N63b670b5792f4042bb2323fa2deb267a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Adult
131 rdf:type schema:DefinedTerm
132 N671aa454c56c46a3bddcd7a56d03435e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Thrombocytopenia
134 rdf:type schema:DefinedTerm
135 N697ccb2281544173aa8552b727d67714 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Antineoplastic Combined Chemotherapy Protocols
137 rdf:type schema:DefinedTerm
138 N6dcc34a178614187963b7034edd05c08 rdf:first sg:person.0732065204.34
139 rdf:rest Nc7165db33e004e3ab7aab4ae60e8e793
140 N839b32609d044142b2735571aec6d84e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N84d8e12281424bcca8cf176153384b42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Hodgkin Disease
145 rdf:type schema:DefinedTerm
146 N8d7252bad0834dbaacb7a30a1a98849a rdf:first sg:person.01000107664.44
147 rdf:rest N8ff5c3a95a0b4bbcaae9937bd6d0f463
148 N8ff5c3a95a0b4bbcaae9937bd6d0f463 rdf:first sg:person.01140223356.38
149 rdf:rest N57f6bae7129e49d9aa5d7c1df6459ee5
150 N9014c3ffe47444f0a5946acb0e803bb9 rdf:first sg:person.01064766557.29
151 rdf:rest N561314a17edf4be5aa37c845a4082c89
152 Na77c3369689c43d1a667cb66883a56fc schema:name readcube_id
153 schema:value 3054faa23264546fc78182f135b50a57b27c1f52777133b244e9429664a988ce
154 rdf:type schema:PropertyValue
155 Naf2480e64f3b452281837d94520e6c7e schema:name nlm_unique_id
156 schema:value 9107334
157 rdf:type schema:PropertyValue
158 Nb9d5f413d1cb4aca8d52916affb98e24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Deoxycytidine
160 rdf:type schema:DefinedTerm
161 Nbae282c1decc48359613a70c68134d5d schema:name pubmed_id
162 schema:value 24158386
163 rdf:type schema:PropertyValue
164 Nbee217737fdf418883d1c9f3ef722e09 schema:issueNumber 5
165 rdf:type schema:PublicationIssue
166 Nc0a234a21818420c97929255b9af1baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Female
168 rdf:type schema:DefinedTerm
169 Nc58b639eba3f40e6af006ca7f64675b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Male
171 rdf:type schema:DefinedTerm
172 Nc67455d176b3495b8e01d23949e551da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Middle Aged
174 rdf:type schema:DefinedTerm
175 Nc7165db33e004e3ab7aab4ae60e8e793 rdf:first sg:person.01320161130.16
176 rdf:rest N00eb8262699e4f28a6870ec54e597e15
177 Ncbb0edf8e015462a875319eb24a463e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Retrospective Studies
179 rdf:type schema:DefinedTerm
180 Nd2a2407556574b8aad07f91a5efc8e24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Adolescent
182 rdf:type schema:DefinedTerm
183 Ne0de740ea7f04740988323814d161b80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Neutropenia
185 rdf:type schema:DefinedTerm
186 Ne2fa6a6738494e92aed97aea1091c1b4 rdf:first sg:person.01000200404.60
187 rdf:rest N6dcc34a178614187963b7034edd05c08
188 Nf6db20da4ac54203b847ab38fc0ad7a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Hematopoietic Stem Cell Transplantation
190 rdf:type schema:DefinedTerm
191 Nf81328d0c5d1410d8fdad160f9b91d08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Cisplatin
193 rdf:type schema:DefinedTerm
194 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
195 schema:name Medical and Health Sciences
196 rdf:type schema:DefinedTerm
197 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
198 schema:name Oncology and Carcinogenesis
199 rdf:type schema:DefinedTerm
200 sg:journal.1018247 schema:issn 1269-3286
201 1279-8509
202 schema:name Annals of Hematology
203 rdf:type schema:Periodical
204 sg:person.01000107664.44 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
205 schema:familyName Wotherspoon
206 schema:givenName Andrew
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000107664.44
208 rdf:type schema:Person
209 sg:person.01000200404.60 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
210 schema:familyName Hawkes
211 schema:givenName Eliza A.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000200404.60
213 rdf:type schema:Person
214 sg:person.01035560774.45 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
215 schema:familyName Chau
216 schema:givenName Ian
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035560774.45
218 rdf:type schema:Person
219 sg:person.01064766557.29 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
220 schema:familyName Dearden
221 schema:givenName Claire
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064766557.29
223 rdf:type schema:Person
224 sg:person.01140223356.38 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
225 schema:familyName Horwich
226 schema:givenName Alan
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140223356.38
228 rdf:type schema:Person
229 sg:person.01320161130.16 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
230 schema:familyName Cunningham
231 schema:givenName David
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16
233 rdf:type schema:Person
234 sg:person.01332410360.78 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
235 schema:familyName Peckitt
236 schema:givenName Clare
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332410360.78
238 rdf:type schema:Person
239 sg:person.016310433302.65 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
240 schema:familyName Potter
241 schema:givenName Mike
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016310433302.65
243 rdf:type schema:Person
244 sg:person.0732065204.34 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
245 schema:familyName Barton
246 schema:givenName Sarah
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732065204.34
248 rdf:type schema:Person
249 sg:person.0737666052.34 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
250 schema:familyName Chua
251 schema:givenName Sue
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737666052.34
253 rdf:type schema:Person
254 sg:pub.10.1007/s00277-009-0734-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027539919
255 https://doi.org/10.1007/s00277-009-0734-6
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/s00277-010-1113-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1045085566
258 https://doi.org/10.1007/s00277-010-1113-z
259 rdf:type schema:CreativeWork
260 sg:pub.10.1023/a:1026454831340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034772808
261 https://doi.org/10.1023/a:1026454831340
262 rdf:type schema:CreativeWork
263 sg:pub.10.1038/sj.bjc.6602514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002994219
264 https://doi.org/10.1038/sj.bjc.6602514
265 rdf:type schema:CreativeWork
266 https://app.dimensions.ai/details/publication/pub.1082379300 schema:CreativeWork
267 https://doi.org/10.1002/cncr.21587 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000306080
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/0140-6736(93)92411-l schema:sameAs https://app.dimensions.ai/details/publication/pub.1047684969
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/j.bbmt.2011.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045304632
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/j.ijrobp.2012.04.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021850522
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1016/s0140-6736(02)08938-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019434820
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1046/j.1365-2141.2003.04226.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010001288
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1056/nejmoa022473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049524002
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1056/nejmoa1100340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009739876
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1080/07357900701788098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005564175
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1080/10245330701214095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058358185
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1080/10428190903040048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015304457
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1093/annonc/mdf221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036637430
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1093/annonc/mdg496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046913073
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1093/annonc/mdi003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042263281
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1093/annonc/mdm090 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016019825
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1111/j.1365-2141.2011.08594.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026107393
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1159/000077995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042104091
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1182/blood-2011-10-388058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013984890
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1182/blood-2011-12-397893 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052251769
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1182/blood-2012-03-418673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042810056
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1200/jco.1999.17.4.1244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549729
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1200/jco.20.2.467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202763
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1200/jco.2011.38.0410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023394934
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1200/jco.2011.38.1350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047229119
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1634/theoncologist.2011-0177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046459955
316 rdf:type schema:CreativeWork
317 https://doi.org/10.3109/10428194.2012.734612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048817281
318 rdf:type schema:CreativeWork
319 https://doi.org/10.3324/haematol.2011.045757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006538660
320 rdf:type schema:CreativeWork
321 https://doi.org/10.3324/haematol.2011.047670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046325083
322 rdf:type schema:CreativeWork
323 https://doi.org/10.3816/clm.2004.n.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046538125
324 rdf:type schema:CreativeWork
325 https://www.grid.ac/institutes/grid.5072.0 schema:alternateName Royal Marsden NHS Foundation Trust
326 schema:name Royal Marsden NHS Foundation Trust, Downs Rd Sutton, SM2 5PT, Surrey, UK
327 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...